Need for new vaccine formulations and potential of particulate antigen and DNA delivery systems

被引：48

作者：

Friede, M ^{[1
]}

Aguado, MT ^{[1
]}

机构：

[1] WHO, Initiat Vaccine Res, CH-1211 Geneva, Switzerland

来源：

ADVANCED DRUG DELIVERY REVIEWS | 2005年 / 57卷 / 03期

关键词：

D O I：

10.1016/j.addr.2004.10.001

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：325 / 331

页数：7

共 23 条

[1]

[Anonymous], [No title captured]

[2] Immunologic studies of specific mucosal and systemic immune responses in Mexican school children after booster aerosol or subcutaneous immunization with measles vaccine [J].

Bellanti, JA ;

Zeligs, BJ ;

Mendez-Inocencio, J ;

García-Garcia, MD ;

Islas-Romero, R ;

Omidvar, B ;

Omidvar, J ;

Kim, G ;

de Castro, JF ;

Amor, JS ;

Walls, L ;

Bellini, WJ ;

Valdespino-Gomez, JL .

VACCINE, 2004, 22 (9-10) :1214-1220

[3] Technologies that make administration of vaccines safer [J].

Clements, CJ ;

Larsen, G ;

Jodar, L .

VACCINE, 2004, 22 (15-16) :2054-2058

[4] Protection against Bordetella pertussis infection following parenteral or oral immunization with antigens entrapped in biodegradable particles:: effect of formulation and route of immunization on induction of Th1 and Th2 cells [J].

Conway, MA ;

Madrigal-Estebas, L ;

McClean, S ;

Brayden, DJ ;

Mills, KHG .

VACCINE, 2001, 19 (15-16) :1940-1950

[5]

Dziekan G, 2003, B WORLD HEALTH ORGAN, V81, P277

[6] INDUCTION OF IMMUNE-RESPONSE AGAINST A SHORT SYNTHETIC PEPTIDE ANTIGEN COUPLED TO SMALL NEUTRAL LIPOSOMES CONTAINING MONOPHOSPHORYL LIPID-A [J].

FRIEDE, M ;

MULLER, S ;

BRIAND, JP ;

VANREGENMORTEL, MHV ;

SCHUBER, F .

MOLECULAR IMMUNOLOGY, 1993, 30 (06) :539-547

[7]

Glenn Gregory M, 2003, Expert Rev Vaccines, V2, P253, DOI 10.1586/14760584.2.2.253

[8]

GLEZEN WP, 2004, EXPERT REV VACCINES, V22, P131

[9] A phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide adjuvant [J].

Halperin, SA ;

Van Nest, G ;

Smith, B ;

Abtahi, S ;

Whiley, H ;

Eiden, JJ .

VACCINE, 2003, 21 (19-20) :2461-2467

[10]

Howard CR, 1997, DRUG TARG D, V8, P1

← 1 2 3 →